COLUMNS
ACCOUNT SPEAK
Treatment of pharma R&D costs
More
BOOKS OF ACCOUNT
‘Accounting was far from enticing’
In a strict historical sense, professions included theology, medicine, and law, writes Joseph Epstein in ‘Why I am not a lawyer’, an essay that comes immediately after ‘Speaking for the dead’ in In a ...
More
CONTRA ENTRY
Global accounting?
Accounting, supposedly, speaks the language of business. With business becoming increasingly globalised, it is logical to expect that accounting, too, goes global. The International Accounting Standards Board (IASB) through a combo offering of ...
More
EAR TO THE GROUND
Betting on Supreme gains
Some players have begun market-making operation in Supreme Industries, betting on its value proposition in view of revenue as well as earnings growth and relatively low market capitalisation. The plastics and plastic product company has reported ...
More
ON THE HEDGE
Nifty future premium widens
It was a strong show by Nifty future as it registered its new peak in its 7-year-old history. The Nifty September future reached a high of 4749 before settling for the day at 4742.70 against the previous day’s close of 4549.80, ...
More
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
|
RSS Feeds